Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Relapse after allogeneic hematopoietic stem cell transplantation (HCT) is the leading cause of death in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Infusion of unselected donor lymphocytes (DLIs) enhances the graft-versus-leukemia (GVL) effect. However, because the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Lulla, Premal D., Naik, Swati, Vasileiou, Spyridoula, Tzannou, Ifigeneia, Watanabe, Ayumi, Kuvalekar, Manik, Lulla, Suhasini, Carrum, George, Ramos, Carlos A., Kamble, Rammurti, Hill, LaQuisa, Randhawa, Jasleen, Gottschalk, Stephen, Krance, Robert, Wang, Tao, Wu, Mengfen, Robertson, Catherine, Gee, Adrian P., Chung, Betty, Grilley, Bambi, Brenner, Malcolm K., Heslop, Helen E., Vera, Juan F., Leen, Ann M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2021
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120140/
https://ncbi.nlm.nih.gov/pubmed/33270816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020009471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados